These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12942109)

  • 1. A phase 1 study of tazarotene in adults with advanced cancer.
    Jones PH; Burnett RD; Fainaru I; Nadolny P; Walker P; Yu Z; Tang-Liu D; Ganesan TS; Talbot DC; Harris AL; Rustin GJ
    Br J Cancer; 2003 Sep; 89(5):808-15. PubMed ID: 12942109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin.
    Yu Z; Sefton J; Lew-Kaya D; Walker P; Yu D; Tang-Liu DD
    Clin Pharmacokinet; 2003; 42(10):921-9. PubMed ID: 12885265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
    Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and biotransformation of the acetylenic retinoid tazarotene in humans.
    Attar M; Yu D; Ni J; Yu Z; Ling KH; Tang-Liu DD
    J Pharm Sci; 2005 Oct; 94(10):2246-55. PubMed ID: 16136553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tazarotene foam versus tazarotene gel: a randomized relative bioavailability study in acne vulgaris.
    Jarratt M; Werner CP; Alió Saenz AB
    Clin Drug Investig; 2013 Apr; 33(4):283-9. PubMed ID: 23456673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
    Tang-Liu DD; Matsumoto RM; Usansky JI
    Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.
    Yu Z; Yu D; Walker PS; Tang-Liu DD
    Clin Pharmacokinet; 2004; 43(10):673-84. PubMed ID: 15244497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety of tazarotene in the treatment of plaque psoriasis.
    Marks R
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S25-32. PubMed ID: 9270553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.
    Kang S; Leyden JJ; Lowe NJ; Ortonne JP; Phillips TJ; Weinstein GD; Bhawan J; Lew-Kaya DA; Matsumoto RM; Sefton J; Walker PS; Gibson JR
    Arch Dermatol; 2001 Dec; 137(12):1597-604. PubMed ID: 11735710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
    Rizvi NA; Marshall JL; Ness E; Yoe J; Gill GM; Truglia JA; Loewen GR; Jaunakais D; Ulm EH; Hawkins MJ
    Clin Cancer Res; 1998 Jun; 4(6):1437-42. PubMed ID: 9626460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of tazarotene.
    Menter A
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S31-5. PubMed ID: 10898827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and safety review of tazarotene.
    Marks R
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S134-8. PubMed ID: 9777791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.
    Krueger GG; Drake LA; Elias PM; Lowe NJ; Guzzo C; Weinstein GD; Lew-Kaya DA; Lue JC; Sefton J; Chandraratna RA
    Arch Dermatol; 1998 Jan; 134(1):57-60. PubMed ID: 9449910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.
    Supko JG; Eder JP; Ryan DP; Seiden MV; Lynch TJ; Amrein PC; Kufe DW; Clark JW
    Clin Cancer Res; 2003 Nov; 9(14):5178-86. PubMed ID: 14613997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors.
    Dees EC; Whitfield LR; Grove WR; Rummel S; Grochow LB; Donehower RC
    Clin Cancer Res; 2000 Oct; 6(10):3885-94. PubMed ID: 11051234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.
    Phillips TJ; Gottlieb AB; Leyden JJ; Lowe NJ; Lew-Kaya DA; Sefton J; Walker PS; Gibson JR;
    Arch Dermatol; 2002 Nov; 138(11):1486-93. PubMed ID: 12437455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, Tolerability, and Pharmacokinetics of Tazarotene Clindamycin Cream: A Single-Dose, 3-Period Crossover Study.
    Li L; Zhang XF; Yang GP; Huang J; Yang XY; Ye L; Guo C; Yang S; Wang XM
    Clin Pharmacol Drug Dev; 2021 Jun; 10(6):598-606. PubMed ID: 33241616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tazarotene therapy for psoriasis, acne vulgaris, and photoaging.
    Guenther LC
    Skin Therapy Lett; 2002 Mar; 7(3):1-4. PubMed ID: 12007011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.
    Park SH; Gray WC; Hernandez I; Jacobs M; Ord RA; Sutharalingam M; Smith RG; Van Echo DA; Wu S; Conley BA
    Clin Cancer Res; 2000 Mar; 6(3):847-54. PubMed ID: 10741706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.